期刊文献+

鼠粒细胞-巨噬细胞集落刺激因子基因转染小鼠黑色素瘤B16F1细胞 被引量:2

Cationic Lipid Mediated the Transaction of mGM-CSF Gene into Murine Melanoma B16F1 Cell Line
下载PDF
导出
摘要 目的 :探讨基因转移载体脂质体介导转染的鼠粒细胞 巨噬细胞集落刺激因子 (mGM CSF)基因在B16F1细胞的表达动态及表达产物的生物活性。方法 :脂质体和质粒DNA复合后 ,转染 10 6B16F1细胞 ,连续 5d换细胞培养液 ,并检测其中的mGM CSF含量。采用 [3 HTdR]渗入法 ,测定DA1G细胞和转染后第一天收获的以 1:10对倍稀释到 1:6 40的上清液及 [3 HTdR]混合培养后 ,渗入到DA1G细胞的 [3 HTdR]量 (cpm) ,以分析表达产物的生物活性。结果 :转染B16F1细胞的mGM CSF基因得到有效表达。但随着时间的推移 ,表达由第 1天的 135ng/ml下降到第 5天的 42 .2ng/ml。渗入到DA1G细胞的 [3 HTdR]量 (cpm)随上清液的稀释而逐步下降 ,由 1:10稀释度的9371下降到 1:6 40时的 32 5 1。和DMEM混合培养的DA1G细胞的 [3 HTdR]渗入量 (cpm)仅为 472。结论 :脂质体作为基因转移载体可有效地介导mGM CSF基因转染B16F1细胞 。 Objective:To examine the expression kinetics and bioactivity of expressed product of mGMCSF gene transfected into B16F1 cells with cationic lipid as a vector in order to explore the potential application of this gene transfer approach.Methods:The lipid-DNA complex was added to B16F1 cells of 10 6.The culture medium of cells was replaced each day for 5 days and mGMCSF expression level was assayed.The expressed mGMCSF was bioassayed by calculating incorporation rate(cpm) of into DA1G cells when DA1G cells were cultivated with diluted culture medium of mGMCSF gene transfected B16F1 cells and . Results: The mGMCSF was efficiently expressed in B16F1 cells and the expression level decreased from 135 ng/ml on day 1 to 42.2 ng/ml on day 5.The incorporation rate(cpm) of into DA1G cells decreased from 9371 at dilution of 1:10 to 3251 at dilution of 1:640,suggesting the expressed mGMCSF had bioactivity. Conclusion:Cationic lipid could efficiently mediate the transfection of mGMCSF gene into B16F1 cells and the transfected mGMCSF gene is expressed with bioactivity.This suggested that the approach of using cationic lipid as gene transfer vector should have potentially applicable promise.
出处 《江西医学院学报》 CAS 2002年第5期10-12,共3页 Acta Academiae Medicinae Jiangxi
关键词 黑色素瘤B16F1细胞 脂质体 粒细胞-巨噬细胞集落刺激因子 基因转移 基因表达 Cationic lipid mGM-CSF gene expression gene transfer
  • 相关文献

参考文献7

  • 1孙卫民,王惠琴.粒细胞-巨噬细胞集落刺激因子.细胞因子研究方法[M].北京:人民卫生出版社,1999.619.
  • 2Shi FS, Weber S,Gan J,et al.Granulocyte-macrophage colony-stimulating factor(GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF[J].Cancer Gene Ther 1999,6(1):81-88.
  • 3Dranoff G,Jaffee E,Lazenby et al.Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent、specific and long-lasting anti-tumor immunity[J].Proc.Natl.Acad.Sci.USA,1993,90(8):3539-3543.
  • 4Ou-Yang P,Hwang LH,Tao MH,et al.Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells[J]. J Med Virol,2002,66(3):320-328.
  • 5Abe J, Wakimoto H,Yoshida Y et al.Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene modified tumor vaccination: comparison of adenovirus-and retrovirus-mediated genetic transduction[J].J Cancer Res.Clin.Oncol,1995,121(9-10):587-592.
  • 6刘金辉,Glenn Larsen.基因转移载体脂质体和重组腺病毒介导碱性磷酸酶基因在B16F1细胞中的表达比较[J].江西医学院学报,2002,42(2):15-18. 被引量:8
  • 7Hernandez A,Zoller K,Enczmann J,Ebert T et al.Differential transfection efficiency rates of the GM-CSF gene into human renal cell carcinoma lines by lipofection[J].Cancer Gene Ther,1997,4(1):59-65.

二级参考文献8

  • 1Watanabe Y, Womoto H, Tekezawa R,et al. Highly efficient transfection into primary cultured mouse hepatocytes by use of cation-liposome: an application for immunization [J]. J Biochem,1994,116(6):1 220-1 226.
  • 2Bramson J L,Graham F L,Gandie J, et al. The use of adenoviral vector for gene therapy and gene transfer in vivo[J]. Curr Opin Biotech, 1995,6: 590- 595.
  • 3Graham F L,Provec L. Methods for construction of adenovirus vectors[J]. Mol Biotech, 1995,3: 207- 220.
  • 4Ye W W,Mason B B,Chengalvala M,et al. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector[J]. Arch Virol, 1991,118: 11 - 27.
  • 5Mittal S K, Mcdermott M R,Jojnson D C, et al. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter[J]. Virus Research, 1993,28: 67 - 90.
  • 6Kojima H,Ohishi N,Takamori M, et al. Cationic multilamellar liposome-mediated gene transfer into primary myoblasts[J]. Biochem Biophys Res Commun, 1995,207( 1 ): 8-12.
  • 7Abe J, Wakimoto H, Yoshida Y, et al. Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene modified tumor vaccination: comparison of adenovirusand retrovirus-mediated genetic transduction[J]. J Cancer Res Clin Oncol, 1995,121(9- 10) :587-592
  • 8许德华,戈凯,郑仲承,刘新垣.腺病毒载体介导的肝癌细胞专一性自杀基因表达[J].生物化学与生物物理学报,1998,30(4):335-338. 被引量:3

共引文献7

同被引文献20

  • 1林青,张海芬,张志敏,许信刚.猪附红细胞体病研究进展[J].畜牧兽医杂志,2004,23(6):19-23. 被引量:10
  • 2范国华,陈生弟,杨卉,戚辰,李琳,巴茂文.人HSP40基因真核表达载体的构建及表达[J].上海交通大学学报(医学版),2006,26(1):54-58. 被引量:2
  • 3李玉保,鲍恩东,王志亮,赵茹茜.荧光定量RT-PCR法检测运输应激猪热休克蛋白mRNA转录水平[J].中国农业科学,2006,39(1):187-192. 被引量:23
  • 4Brindley PJ, Kalinna BH, Dalton JP, et al. Proteolytic Degradation of Host Hemoglobin by Schistosomes[J]. Mol Biochem Parasitol, 1997, 89:81-91.
  • 5Dalton JP, Smith AM, Clough KA, et al. Digestion of Haemoglobin by Schistosomes[J]. Parasitol Today, 1995, 11: 3019-3031.
  • 6Day SR, Dalton JP, Clough KA, et al. Characterization and Cloning of the Cathepsin L Proteinases of Schistosoma japonlcum [J]. Biochem Biophys Res Comm,1995, 217:81-91.
  • 7Brady CP, Dowd AJ, Brindley PJ, et al. Recombinant Expression and Localization of Schistosoma mansoni Cathepsin L1 Support Its Role in the Degradation of Host Hemoglobin[J]. Infection and Immunity, 1999, 67(1) : 368-374.
  • 8Brady CP, Dowd AJ, Brindley PJ, et al. Recombinant Expression and Localization of Schistosoma mansoni Cathepsin L1 Support Its Role in the Degradation of Host Hemoglobin[J]. Infection and Immunity, 1999, 67(2): 15-17.
  • 9X. -B. Qiu,Y. -M. Shao,S. Miao,L. Wang.The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones[J].Cellular and Molecular Life Sciences.2006(22)
  • 10Morishita R,Aoki M,Hashiya N,et al.Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease[].Journal of Hypertension.2004

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部